Publications by authors named "Emanuele Zucca"

100Publications

Marginal Zone Lymphomas.

Cancer J 2020 Jul/Aug;26(4):336-347

From the Institute of Oncology Research, Faculty of Biomedical Sciences, USI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000463DOI Listing
August 2020

Immunomodulatory drugs may overcome the negative prognostic role of active Th17 axis in follicular lymphoma: evidence from the SAKK35/10 trial.

Br J Haematol 2020 Jun 11. Epub 2020 Jun 11.

Institute of Pathology and Medical Genetics, University Hospital Basel, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16876DOI Listing
June 2020

Risk factors for renal toxicity after inpatient cisplatin administration.

BMC Pharmacol Toxicol 2020 03 2;21(1):19. Epub 2020 Mar 2.

Istituto Oncologico della Svizzera Italiana (IOSI), Oncology Clinic, Via Ospedale 12, 6500, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40360-020-0398-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052961PMC
March 2020

Sciatic pain by neurolymphomatosis as initial presentation of disseminated diffuse large B cell lymphoma involving the testis and the CNS.

Hematol Oncol 2020 Apr 5;38(2):197-200. Epub 2020 Feb 5.

Oncology Institute of Southern Switzerland (IOSI), Medical Oncology, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2698DOI Listing
April 2020

The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15-ICML workshop on ctDNA.

Hematol Oncol 2020 Feb 30;38(1):34-37. Epub 2019 Dec 30.

National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2704DOI Listing
February 2020

Use of epirubicin to treat diffuse large B-cell lymphoma.

Lancet Haematol 2019 06;6(6):e292-e293

Ospedale San Giovanni, Bellinzona 6500, Switzerland; Division of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Department of Medical Oncology, Inselspital-Bern University Hospital, Bern, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30082-1DOI Listing
June 2019

In vitro demonstration of synergism with pixantrone combined with targeted agents in lymphomas.

Br J Haematol 2019 07 19;186(1):149-152. Epub 2018 Dec 19.

Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15727DOI Listing
July 2019

Fine-needle aspiration to diagnose primary thyroid lymphomas: a systematic review and meta-analysis.

Eur J Endocrinol 2019 Mar;180(3):177-187

Department of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
https://eje.bioscientifica.com/view/journals/eje/aop/eje-18-
Publisher Site
http://dx.doi.org/10.1530/EJE-18-0672DOI Listing
March 2019

Foreword.

Eur J Intern Med 2018 12 27;58. Epub 2018 Nov 27.

Institute of Oncology Research, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2018.11.006DOI Listing
December 2018

Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma.

Curr Oncol Rep 2018 08 22;20(10):79. Epub 2018 Aug 22.

Institute of Oncology Research (IOR), Via Vela 6, 6500, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-018-0728-4DOI Listing
August 2018

Recent advances in understanding the biology of marginal zone lymphoma.

F1000Res 2018 28;7:406. Epub 2018 Mar 28.

Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.13826.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874504PMC
March 2018

Novel acquisitions on biology and management of transformed follicular lymphoma.

Hematol Oncol 2018 Oct 30;36(4):617-623. Epub 2018 Mar 30.

Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2508DOI Listing
October 2018

Tailoring treatment for MALT lymphoma patients: where do we stand now?

Oncotarget 2017 Dec 6;8(70):114422-114423. Epub 2017 Dec 6.

International Extranodal Lymphoma Study Group (IELSG), Foundation for the Research and Cure of Lymphoma in Ticino, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.23001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777700PMC
December 2017

A MALT lymphoma prognostic index.

Blood 2017 09 18;130(12):1409-1417. Epub 2017 Jul 18.

Lymphoma Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-03-771915DOI Listing
September 2017

Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015.

Hematol Oncol 2017 Dec 4;35(4):397-407. Epub 2017 Apr 4.

Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2411DOI Listing
December 2017

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

J Clin Oncol 2017 Jun 29;35(17):1905-1912. Epub 2017 Mar 29.

Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andrés J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia; Umberto Vitolo, University-Hospital Città della Salute e della Scienza, Turin; Maurizio Martelli, Sapienza University; Stefan Hohaus, Catholic University of the Sacred Heart, Rome; Graziella Pinotti, Fondazione Macchi Hospital, Varese; Caterina Stelitano, Bianchi-Melacrino-Morelli Hospitals, Reggio Calabria; Monica Bellei, University of Modena and Reggio Emilia, Modena, Italy; Reda Bouabdallah, Institut Paoli-Calmettes, Marseille; Gilles Salles, Hospices Civils de Lyon and Université Claude Bernard Lyon-1, Pierre-Benite; Catherine Sebban, Centre Léon Bérard, Lyon; Franck Morschhauser, Claude Huriez Hospital, Lille; Anne Moreau, University Hospital of Nantes, Nantes; Hervé Tilly, Centre Henri Becquerel, Rouen; Corinne Haioun, Henri-Mondor Hospital, Paris Créteil; Corinne Haioun, UPEC, Assistance Publique-Hopitaux de Paris; Catherine Thieblemont, Assistance Publique-Hopitaux de Paris, Hôpital-Saint-Louis, Hematooncology-Université Paris Diderot, Sorbonne Paris-Cité, Paris, France; Ruth Pettengell, St George's University of London, London; Andrew Jack, St James's University Hospital, Leeds; Peter Johnson, Southampton General Hospital, Southampton, United Kingdom; Armando Lopez Guillermo and Elias Campo, Hospital Clinic, Barcelona, Spain; Pierre Zachée, ZNA Stuivenberg, Antwerp; and André Bosly, Mont-Godinne UCL, Yvoir, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.6994DOI Listing
June 2017

Clinical aspects and therapy of gastrointestinal MALT lymphoma.

Best Pract Res Clin Haematol 2017 Mar - Jun;30(1-2):109-117. Epub 2017 Jan 30.

Lymphoma Unit, Division of Research, Oncology Institute of Southern Switzerland (IOSI), Ospedale San Giovanni, 6500 Bellinzona, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2017.01.002DOI Listing
October 2017

Marginal zone lymphomas: Reconsidering similarities and differences while moving towards personalized treatment.

Best Pract Res Clin Haematol 2017 Mar - Jun;30(1-2):1-4. Epub 2016 Dec 18.

Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2016.12.001DOI Listing
February 2019

In Reply to Adams and Kwee.

Int J Radiat Oncol Biol Phys 2017 03 10;97(4):870-871. Epub 2016 Dec 10.

Department of Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.12.001DOI Listing
March 2017

Rituximab: 13 open questions after 20years of clinical use.

Cancer Treat Rev 2017 Feb 22;53:38-46. Epub 2016 Dec 22.

Oncology Institute of Southern Switzerland, Ospedale San Giovanni, 6500 Bellinzona, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.11.015DOI Listing
February 2017

The landscape of new drugs in lymphoma.

Nat Rev Clin Oncol 2017 Jun 29;14(6):335-346. Epub 2016 Dec 29.

UNMC Oncology/Haematology Division, 987680 Nebraska Medical Center, Omaha, Nebraska 681980-7680, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611863PMC
June 2017

Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials.

J Clin Oncol 2017 Feb 28;35(5):552-560. Epub 2016 Dec 28.

Qian Shi and Daniel J. Sargent, Mayo Clinic, Rochester; Bruce A. Peterson, University of Minnesota, Minneapolis, MN; Christopher R. Flowers, Winship Cancer Institute of Emory University, Atlanta, GA; Wolfgang Hiddemann and Eva Hoster, Ludwig-Maximilians University Hospital, Munich; Michael Herold, HELIOS Kliniken, Erfurt, Germany; Robert Marcus, Addenbrooke's Hospital, Cambridge, United Kingdom; Anton Hagenbeek, Academic Medical Center, Amsterdam, the Netherlands; Eva Kimby, Karolinska Institutet, Stockholm, Sweden; Howard Hochster, Yale Cancer Center, New Haven, CT; Umberto Vitolo, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin; Marco Ladetto, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; Emmanuel Gyan, University Hospital, Tours; Franck Morschhauser, Service Université de Lille 2, Lille; Gilles Salles, Université Claude Bernard, Pierre Bénite, France; Michele Ghielmini and Emanuele Zucca, Oncology Institute of Southern Switzerland, Bellinzona; Michele Ghielmini and Emanuele Zucca, Swiss Group for Clinical Cancer Research, Bern; Tina Nielsen, F. Hoffmann-La Roche, Basel; Sabine De Bedout, Celgene, Boudry, Switzerland; Tommy Fu, Celgene, Summit, NJ; Nancy Valente, Genentech, South San Francisco, CA; and Nathan H. Fowler, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.8651DOI Listing
February 2017

Systemic Front Line Therapy of Follicular Lymphoma: When, to Whom and How.

Mediterr J Hematol Infect Dis 2016 7;8(1):e2016062. Epub 2016 Nov 7.

Istituto Oncologico della Svizzera Italiana, Ospedale San Giovanni 6500 Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2016.062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111519PMC
November 2016

Is there a role for a maintenance rituximab in indolent lymphoproliferative diseases other than follicular lymphoma?

Leuk Lymphoma 2017 01 4;58(1):30-36. Epub 2016 Nov 4.

a Department of Medical Oncology , Oncology Institute of Southern Switzerland , Bellinzona , Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1248963DOI Listing
January 2017

Functional Imaging Using 18-Fluorodeoxyglucose PET in the Management of Primary Mediastinal Large B-Cell Lymphoma: The Contributions of the International Extranodal Lymphoma Study Group.

Am Soc Clin Oncol Educ Book 2016 ;35:e368-75

From the Oncology Institute of Southern Switzerland, Lymphoma Unit-Ospedale San Giovanni, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_159037DOI Listing
January 2017

Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?

Ther Adv Hematol 2016 Apr 29;7(2):94-107. Epub 2015 Dec 29.

Lymphoma Unit, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona 6500, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620715623924DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802504PMC
April 2016

The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance.

Blood 2016 04 17;127(17):2082-92. Epub 2016 Mar 17.

Lymphoma Unit/Division of Research, Oncology Institute of Southern Switzerland (IOSI), Ospedale San Giovanni, Bellinzona, Switzerland; and Lymphoma and Genomics Research Program, Institute of Oncology Research (IOR), Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-12-624304DOI Listing
April 2016

Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03.

J Clin Oncol 2016 Feb 28;34(5):495-500. Epub 2015 Dec 28.

Christian Taverna, Kantonsspital Münsterlingen, Münsterlingen; Felicitas Hitz, Kantonsspital St Gallen, St Gallen; Walter Mingrone, Kantonsspital Aarau/Olten, Olten; Thomas Pabst, Inselspital Bern; Christine Biaggi Rudolf, Stéphanie Rondeau, and Corinne Rusterholz, Swiss Group for Clinical Cancer Research SAKK, Bern; Daniel Rauch, Spital Thun Simmental, Thun; Andreas Lohri, Kantonsspital Liestal, Liestal; Ingmar A.F.M. Heijnen, University Hospital Basel, Basel; Emanuele Zucca and Michele Ghielmini, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Giovanni Martinelli, Anna Vanazzi, and Daniele Laszlo, Istituto Europeo di Oncologia, Milan, Italy; Lidija Cevreska, University Clinic for Hematology, Skopje, Macedonia; Auro del Giglio, ABC Fondation School of Medicine, Sao Paulo, Brazil; Johann Raats, Panorama Oncology Unit, Cape Town; and Daniel A. Vorobiof, Sandton Oncology Center, Johannesburg, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.3968DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872010PMC
February 2016

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41).

Oncologist 2015 Oct 12;20(10):1149-53. Epub 2015 Aug 12.

Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota USA; Hospital of Bolzano, Department of Hematology & Center of Bone Marrow Transplantation, Bolzano, Italy; Department of Hematology and Oncology, University Hospital Innsbruck, Innsbruck, Austria; University Hospital of Crete, Heraklion, Greece; Athens Medical Center-Psychikon Branch, Athens, Greece; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Hematology Unit, Department of Internal Medicine, Ospedale degli Infermi, Biella, Italy; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy; Hospital Clínic, Hematology, Barcelona, Spain; Cancer Research UK Centre, Southampton, United Kingdom; Dipartimento Biotecnologie Cellulari ed Ematologia, Universitá La Sapienza, Rome, Italy; European Institute of Oncology, Division of Clinical Haemato-Oncology, Milan, Italy; APHP, Saint-Louis Hospital, Hemato-Oncology, and Diderot University-Sorbonne Paris Cité, Paris, France; Département de Pathologie, Groupe Henri Mondor-Albert Chenevier, AP-HP, Creteil, France; Diagnostic Haematopathology, European Institute of Oncology, Milan, Bologna University School of Medicine, Bologna, Italy; St. James's University Hospital, Leeds, United Kingdom; Hospital Clinic, Anatomia Patologica, IDIBAPS, Barcelona, Spain; ICP Locarno, Locarno, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591947PMC
October 2015

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).

J Clin Oncol 2015 Aug 6;33(23):2523-9. Epub 2015 Jul 6.

Christoph Mamot and Mario Bargetzi, Cantonal Hospital Aarau, Aarau; Dirk Klingbiel, Christine Biaggi, and Corinne Rusterholz, Swiss Group for Clinical Cancer Research Coordinating Center; Thomas Pabst, Inselspital Bern, Bern; Felicitas Hitz and Christoph Driessen, Cantonal Hospital St. Gallen, St. Gallen; Christoph Renner, Hirslanden Zürich; Thomas Hany, Magnetic Resonance Imaging Roentgen Zürich; Andrei Samarin, University Hospital Zürich, Zürich; Ulrich Mey, Cantonal Hospital Graubuenden, Chur; Miklos Pless, Cantonal Hospital Winterthur, Winterthur; Fatime Krasniqi and Stephan Dirnhofer, University Hospital of Basel, Basel; Emanuele Zucca, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; and Federica Gigli and Giovanni Martinelli, European Institute of Oncology Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.9846DOI Listing
August 2015

A case of Hodgkin lymphoma in a patient with a history of bone pain and an initial diagnosis of chronic osteomyelitis.

Tumori 2015 Jun 25;101(3):e99-e102. Epub 2015 Jun 25.

1 Lymphoma Unit, Oncology Institute of Southern Switzerland, Bellinzona - Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/tj.5000283DOI Listing
June 2015

Primary extranodal B-cell lymphoma: current concepts and treatment strategies.

Chin Clin Oncol 2015 Mar;4(1):10

Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2014.12.01DOI Listing
March 2015

Primary and secondary bone lymphomas.

Cancer Treat Rev 2015 Mar 7;41(3):235-46. Epub 2015 Feb 7.

Unit of Lymphoid Malignancies, Department of Onco-Haematology, San Raffaele Scientific Institute, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2015.02.001DOI Listing
March 2015

Hepatitis C virus-associated B-cell non-Hodgkin lymphomas.

Hematology Am Soc Hematol Educ Program 2014 Dec 18;2014(1):590-8. Epub 2014 Nov 18.

Lymphoma Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://www.asheducationbook.org/cgi/doi/10.1182/asheducation
Publisher Site
http://dx.doi.org/10.1182/asheducation-2014.1.590DOI Listing
December 2014

Management of the marginal zone lymphomas.

Cancer Treat Res 2015 ;165:227-49

Lymphoma Unit, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, 6500, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-13150-4_9DOI Listing
April 2015

Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas.

Br J Haematol 2015 Mar 6;168(6):771-83. Epub 2015 Jan 6.

Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA; Department of Pathology, NYU Cancer Center, New York University School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13265DOI Listing
March 2015

In reply.

Oncologist 2014 Dec;19(12):1289-90

Premion and Bond University, Tugun, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257746PMC
December 2014

Emerging role of infectious etiologies in the pathogenesis of marginal zone B-cell lymphomas.

Clin Cancer Res 2014 Oct;20(20):5207-16

Lymphoma Unit, Division of Research, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0496DOI Listing
October 2014

Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.

Cancer Treat Rev 2014 Oct 24;40(9):1080-8. Epub 2014 Aug 24.

Institute of Hematology "Seràgnoli", University of Bologna, Via Massarenti 9, 40138 Bologna, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2014.08.001DOI Listing
October 2014

PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas.

Leuk Lymphoma 2015 May 7;56(5):1223-8. Epub 2014 Oct 7.

Department of Pathology and Laboratory Medicine, Weill Cornell Medical College , New York, NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.953155DOI Listing
May 2015

Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis.

Hematol Oncol 2015 Sep 22;33(3):113-24. Epub 2014 Jul 22.

Department of Nuclear Medicine and PET/CT Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2152DOI Listing
September 2015

[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.

J Clin Oncol 2014 Jun 5;32(17):1769-75. Epub 2014 May 5.

Maurizio Martelli and Erica Finolezzi, Sapienza University, Rome; Pier Luigi Zinzani and Stefano A. Pileri, Policlinico S. Orsola-Malpighi, Bologna; Andrés J.M. Ferreri, San Raffaele Scientific Institute, Milan; Umberto Vitolo, Azienda Ospedaliera S. Giovanni Battista, Torino; Caterina Stelitano, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria; Ercole Brusamolino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia; Maria Giuseppina Cabras, Ospedale Businco, Cagliari; Luigi Rigacci, Policlinico Careggi, Florence; Monica Balzarotti, IRCCS Humanitas, Rozzano; Flavia Salvi, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; Luca Ceriani, Emanuele Zucca, Franco Cavalli, and Luca Giovanella, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Silvia Montoto, Barts Cancer Institute, London; Andrew Davies and Peter W.M. Johnson, University of Southampton, Southampton, United Kingdom; and Armando Lopez-Guillermo, Hospital Clinic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.7524DOI Listing
June 2014

The management of nongastric MALT lymphomas.

Oncology (Williston Park) 2014 Jan;28(1):86-93

View Article

Download full-text PDF

Source
January 2014

Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.

Br J Haematol 2014 Jul 27;166(1):69-76. Epub 2014 Mar 27.

Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, AOU Maggiore della Carità, Novara, Italy; Haematology Unit, Department of Internal Medicine, Ospedale degli Infermi, Biella, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12845DOI Listing
July 2014